Dragomir Krastev

11PUBLICATIONS
109CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumoursMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 22, 2026
The anion channel GPR89 is a tumor-specific dependency in breast cancer.

|Sep 21, 2026
PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer.

|Jun 02, 2026
Nucleophagy removes cytotoxic trapped PARP1.

|Mar 12, 2026
Tumour specific HORMAD1 expression perturbs mitotic arrest and drives sensitivity to mitotic kinase inhibitors.

Callum Walker, Gabriel Kollarovic, Daniel Weekes

|Jul 29, 2025
Autocrine interferon poisoning mediates ADAR1-dependent synthetic lethality in BRCA1/2-mutant cancers.

Roman M Chabanon, Liudmila Shcherbakova, Magali Lacroix-Triki

|Jul 08, 2025
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models.

Joan Kyula-Currie, Victoria Roulstone, James Wright

Pageof 2

Frequent Collaborators

11 joint publications

Christopher J Lord

9 joint publications

Stephen Pettitt

7 joint publications

Andrew Tutt

7 joint publications

Jyoti S Choudhary